CSBR:NASDAQ
Champions Oncology Inc
US$4,70
0,00%
(0,00) 1D
13 ພ.ຈ., 15 ໂມງ 57 ນາທີ 39 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Mkt. cap
65,49 ລ້ານ
Avg. vol.
8,15 ພັນ
Volume
212,00
52-wk high
US$8,31
52-wk low
US$4,52
EPS
US$-0,08
Beta
0,47
Shares outstanding
13,92 ລ້ານ
No. of employees
217
Mkt. cap
65,49 ລ້ານ
Avg. vol.
8,15 ພັນ
Volume
212,00
52-wk high
US$8,31
52-wk low
US$4,52
EPS
US$-0,08
Beta
0,47
Shares outstanding
13,92 ລ້ານ
No. of employees
217
News stories
From web sources and news partners
24/7 Wall St.
·
23 ນາທີກ່ອນ
S&P 500 Drops 1.1% at Midday as Nasdaq Leads the Selloff
Benzinga
·
41 ນາທີກ່ອນ
Forget Nvidia — S&P 500's 8,900 Target Puts These ETFs in Play - State Street SPDR S&P 500 ETF Trust (ARC
Trading News
·
28 ນາທີກ່ອນ
Stock Market Today: S&P 500 SPX (7,562) 7,812 Target, Nasdaq, Dow, NVDA -3.7%
BigGo Finance
·
3 ຊົ່ວໂມງກ່ອນ
Bitget Opens Onchain Yield Vaults for Tokenized S&P 500, Nasdaq-100 Trackers
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, ນິວເຈີຊີ, ສະຫະລັດ
SectorHealth Care
Industry-
Websitechampionsoncology.com